Netflix's board of directors on Friday adopted a stockholder rights plan, commonly known as a poison-pill defense, to keep activist investor Carl Icahn from acquiring more shares in the company. Icahn, who owns nearly 10% of Netflix's shares, said in a regulatory filing that the company's new poison pill was "particularly troubling" and criticized Netflix for "poor corporate governance."